Published in Clin Exp Metastasis on April 01, 2014
Molecular signatures of lymph node status by intrinsic subtype: gene expression analysis of primary breast tumors from patients with and without metastatic lymph nodes. J Exp Clin Cancer Res (2014) 0.80
Breast Cancer Metastasis to the Axillary Lymph Nodes: Are Changes to the Lymph Node "Soil" Localized or Systemic? Breast Cancer (Auckl) (2017) 0.75
Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods (2001) 414.27
The basics of epithelial-mesenchymal transition. J Clin Invest (2009) 32.82
Involvement of chemokine receptors in breast cancer metastasis. Nature (2001) 26.07
Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits. Nat Rev Cancer (2009) 18.53
Metastasis: from dissemination to organ-specific colonization. Nat Rev Cancer (2009) 14.17
Putting tumours in context. Nat Rev Cancer (2001) 12.37
Stromal gene expression predicts clinical outcome in breast cancer. Nat Med (2008) 10.68
Twenty-five-year follow-up of a randomized trial comparing radical mastectomy, total mastectomy, and total mastectomy followed by irradiation. N Engl J Med (2002) 7.66
TGFbeta primes breast tumors for lung metastasis seeding through angiopoietin-like 4. Cell (2008) 7.60
Genetic determinants of cancer metastasis. Nat Rev Genet (2007) 6.38
A novel clathrin adaptor complex mediates basolateral targeting in polarized epithelial cells. Cell (1999) 5.19
Tumour-infiltrating regulatory T cells stimulate mammary cancer metastasis through RANKL-RANK signalling. Nature (2011) 4.57
Regulation of in situ to invasive breast carcinoma transition. Cancer Cell (2008) 4.46
Cancer stem cells and epithelial-mesenchymal transition: concepts and molecular links. Semin Cancer Biol (2012) 3.98
Preparing the "soil": the premetastatic niche. Cancer Res (2006) 2.92
Rapid cell corpse clearance by stabilin-2, a membrane phosphatidylserine receptor. Cell Death Differ (2007) 2.44
Hematopoietic prostaglandin D2 synthase controls the onset and resolution of acute inflammation through PGD2 and 15-deoxyDelta12 14 PGJ2. Proc Natl Acad Sci U S A (2007) 2.10
Mesenchymal transition and dissemination of cancer cells is driven by myeloid-derived suppressor cells infiltrating the primary tumor. PLoS Biol (2011) 1.92
Loss of FOXA1/2 is essential for the epithelial-to-mesenchymal transition in pancreatic cancer. Cancer Res (2010) 1.69
RB and c-Myc activate expression of the E-cadherin gene in epithelial cells through interaction with transcription factor AP-2. Mol Cell Biol (1998) 1.39
Critical and reciprocal regulation of KLF4 and SLUG in transforming growth factor β-initiated prostate cancer epithelial-mesenchymal transition. Mol Cell Biol (2011) 1.34
Identification of primary gene targets of TFAP2C in hormone responsive breast carcinoma cells. Genes Chromosomes Cancer (2010) 1.27
Sentinel lymph node as a target of molecular diagnosis of lymphatic micrometastasis and local immunoresponse to malignant cells. Cancer Sci (2007) 1.16
Identification of differentially expressed genes in breast tumors from African American compared with Caucasian women. Cancer (2011) 1.14
T cell-derived protein S engages TAM receptor signaling in dendritic cells to control the magnitude of the immune response. Immunity (2013) 1.14
New insights into the mechanisms of organ-specific breast cancer metastasis. Semin Cancer Biol (2012) 1.10
Anterior gradient-2 plays a critical role in breast cancer cell growth and survival by modulating cyclin D1, estrogen receptor-alpha and survivin. Breast Cancer Res (2010) 1.03
Phenotype-dependent effects of EpCAM expression on growth and invasion of human breast cancer cell lines. BMC Cancer (2012) 1.03
The estrogen-regulated anterior gradient 2 (AGR2) protein in breast cancer: a potential drug target and biomarker. Breast Cancer Res (2013) 1.02
AZGP1 is a tumor suppressor in pancreatic cancer inducing mesenchymal-to-epithelial transdifferentiation by inhibiting TGF-β-mediated ERK signaling. Oncogene (2010) 1.01
Radiation therapy in the management of breast cancer. Surg Clin North Am (2013) 0.99
Mesenchymal stem cells promote mammary cancer cell migration in vitro via the CXCR2 receptor. Cancer Lett (2011) 0.98
The role of CXC chemokines and their receptors in the progression and treatment of tumors. J Mol Histol (2012) 0.92
Analysis of EpCAM positive cells isolated from sentinel lymph nodes of breast cancer patients identifies subpopulations of cells with distinct transcription profiles. Breast Cancer Res (2011) 0.92
The estrogen-responsive Agr2 gene regulates mammary epithelial proliferation and facilitates lobuloalveolar development. Dev Biol (2012) 0.90
Altered local and systemic immune profiles underlie lymph node metastasis in breast cancer patients. Int J Cancer (2012) 0.89
FXYD3 protein involved in tumor cell proliferation is overproduced in human breast cancer tissues. Biol Pharm Bull (2009) 0.88
Mitogenic effect of the 15-kDa gross cystic disease fluid protein (GCDFP-15) on breast-cancer cell lines and on immortal mammary cells. Int J Cancer (1995) 0.84
TFPI alpha and beta regulate mRNAs and microRNAs involved in cancer biology and in the immune system in breast cancer cells. PLoS One (2012) 0.80
Glycyl tRNA synthetase mutations in Charcot-Marie-Tooth disease type 2D and distal spinal muscular atrophy type V. Am J Hum Genet (2003) 3.55
Loss of nuclear localized and tyrosine phosphorylated Stat5 in breast cancer predicts poor clinical outcome and increased risk of antiestrogen therapy failure. J Clin Oncol (2011) 2.78
Reporting, appraising, and integrating data on genotype prevalence and gene-disease associations. Am J Epidemiol (2002) 2.56
Genetic epidemiology of insulin resistance and visceral adiposity. The IRAS Family Study design and methods. Ann Epidemiol (2003) 2.51
Clinical trial results of a HER2/neu (E75) vaccine to prevent recurrence in high-risk breast cancer patients. J Clin Oncol (2005) 2.43
Assessing semantic similarity measures for the characterization of human regulatory pathways. Bioinformatics (2006) 2.29
Slow molecular clocks in Old World monkeys, apes, and humans. Mol Biol Evol (2002) 2.20
Circulating MMP2 and MMP9 in breast cancer -- potential role in classification of patients into low risk, high risk, benign disease and breast cancer categories. Int J Cancer (2006) 2.00
The genomic heritage of lymph node metastases: implications for clinical management of patients with breast cancer. Ann Surg Oncol (2008) 1.87
Genomic alterations associated with early stages of breast tumor metastasis. Ann Surg Oncol (2008) 1.61
Standard versus pH-adjusted and lidocaine supplemented radiocolloid for patients undergoing sentinel-lymph-node mapping and biopsy for early breast cancer (PASSION-P trial): a double-blind, randomised controlled trial. Lancet Oncol (2009) 1.57
Prospective trial of voice outcomes after thyroidectomy: evaluation of patient-reported and clinician-determined voice assessments in identifying postthyroidectomy dysphonia. Surgery (2008) 1.53
Correlation of levels and patterns of genomic instability with histological grading of DCIS. Ann Surg Oncol (2007) 1.47
Heritability of coronary artery calcium quantity measured by electron beam computed tomography in asymptomatic adults. Circulation (2002) 1.46
The impact of recurrent laryngeal neuromonitoring on multi-dimensional voice outcomes following thyroid surgery. J Surg Oncol (2011) 1.46
A gene expression signature that defines breast cancer metastases. Clin Exp Metastasis (2008) 1.34
Functional identity of genes detectable in expression profiling assays following globin mRNA reduction of peripheral blood samples. Clin Biochem (2007) 1.25
A prospective evaluation of patients undergoing surgery for the palliation of an advanced malignancy. Ann Surg Oncol (2002) 1.25
High-throughput loss of heterozygosity mapping in 26 commonly deleted regions in breast cancer. Cancer Epidemiol Biomarkers Prev (2003) 1.20
Effect of ASCO/CAP guidelines for determining ER status on molecular subtype. Ann Surg Oncol (2012) 1.14
Identification of differentially expressed genes in breast tumors from African American compared with Caucasian women. Cancer (2011) 1.14
Development of a Bayesian classifier for breast cancer risk stratification: a feasibility study. Eplasty (2010) 1.14
Outer breast quadrants demonstrate increased levels of genomic instability. Ann Surg Oncol (2004) 1.08
Evaluation of the CD107 cytotoxicity assay for the detection of cytolytic CD8+ cells recognizing HER2/neu vaccine peptides. Breast Cancer Res Treat (2005) 1.06
The use of rapid parathyroid hormone assay in predicting postoperative hypocalcemia after total or completion thyroidectomy. Thyroid (2006) 1.06
Proteomics of breast carcinoma. J Chromatogr B Analyt Technol Biomed Life Sci (2005) 1.04
Investigating the combination of trastuzumab and HER2/neu peptide vaccines for the treatment of breast cancer. Ann Surg Oncol (2006) 1.03
Breast cancer in the personal genomics era. Curr Genomics (2010) 1.02
Assessing serum cytokine profiles in breast cancer patients receiving a HER2/neu vaccine using Luminex technology. Oncol Rep (2007) 1.02
Electrical impedance scanning for the early detection of breast cancer in young women: preliminary results of a multicenter prospective clinical trial. J Clin Oncol (2005) 1.00
Core biopsy diagnosis of ductal carcinoma in situ: an indication for sentinel lymph node biopsy. Curr Surg (2005) 1.00
Lung cancer survival among black and white patients in an equal access health system. Cancer Epidemiol Biomarkers Prev (2012) 0.99
DW4TR: A Data Warehouse for Translational Research. J Biomed Inform (2011) 0.99
Speckle echocardiographic left atrial strain and stiffness index as predictors of maintenance of sinus rhythm after cardioversion for atrial fibrillation: a prospective study. Cardiovasc Ultrasound (2012) 0.99
Performance of whole-genome amplified DNA isolated from serum and plasma on high-density single nucleotide polymorphism arrays. J Mol Diagn (2008) 0.98
Genomic instability in histologically normal breast tissues: implications for carcinogenesis. Lancet Oncol (2004) 0.98
Improvement in psychosocial functioning during an intensive cardiovascular lifestyle modification program. J Cardiopulm Rehabil Prev (2008) 0.98
Detecting outlier microarray arrays by correlation and percentage of outliers spots. Cancer Inform (2007) 0.98
Low levels of Stat5a protein in breast cancer are associated with tumor progression and unfavorable clinical outcomes. Breast Cancer Res (2012) 0.96
The evaluation of casualties from Operation Iraqi Freedom on return to the continental United States from March to June 2003. J Am Coll Surg (2005) 0.95
Correlations between serum monocyte chemotactic protein-1 levels, clinical prognostic factors, and HER-2/neu vaccine-related immunity in breast cancer patients. Clin Cancer Res (2006) 0.95
Prospective study of electrical impedance scanning for identifying young women at risk for breast cancer. Breast Cancer Res Treat (2006) 0.93
Plasma concentration and activity of matrix metalloproteinase 2 and 9 in patients with breast disease, breast cancer and at risk of developing breast cancer. Cancer Lett (2006) 0.93
HYOU1/Orp150 expression in breast cancer. Med Sci Monit (2007) 0.93
Socioeconomic disparities and breast cancer hormone receptor status. Cancer Causes Control (2012) 0.92
Race and colon cancer survival in an equal-access health care system. Cancer Epidemiol Biomarkers Prev (2013) 0.92
Effects of cardiovascular lifestyle change on lipoprotein subclass profiles defined by nuclear magnetic resonance spectroscopy. Lipids Health Dis (2009) 0.91
Autologous pancreatic islet transplantation for severe trauma. N Engl J Med (2010) 0.90
Does breast tumor heterogeneity necessitate further immunohistochemical staining on surgical specimens? J Am Coll Surg (2012) 0.89
Amplification of HER2 is a marker for global genomic instability. BMC Cancer (2008) 0.88
Proteomic profiling of human urine using multi-dimensional protein identification technology. J Chromatogr A (2005) 0.88
Genomic patterns of allelic imbalance in disease free tissue adjacent to primary breast carcinomas. Breast Cancer Res Treat (2004) 0.88
Electrical impedance scanning as a new breast cancer risk stratification tool for young women. J Surg Oncol (2008) 0.88
Global search for chromosomal abnormalities in infiltrating ductal carcinoma of the breast using array-comparative genomic hybridization. Cancer Genet Cytogenet (2004) 0.88
Preoperative thyroid ultrasound in all patients undergoing parathyroidectomy? J Surg Res (2008) 0.87
Leukocyte DNA as surrogate for the evaluation of imprinted Loci methylation in mammary tissue DNA. PLoS One (2013) 0.87
Socioeconomic disparities in colorectal cancer mortality in the United States, 1990-2007. J Community Health (2014) 0.87
Laser microdissection for gene expression profiling. Methods Mol Biol (2011) 0.86
A Bayesian derived network of breast pathology co-occurrence. J Biomed Inform (2008) 0.86
Correlation of levels and patterns of genomic instability with histological grading of invasive breast tumors. Breast Cancer Res Treat (2007) 0.86
Levels of circulating regulatory CD4+CD25+ T cells are decreased in breast cancer patients after vaccination with a HER2/neu peptide (E75) and GM-CSF vaccine. Breast Cancer Res Treat (2006) 0.85
Analysis of naïve and memory CD4 and CD8 T cell populations in breast cancer patients receiving a HER2/neu peptide (E75) and GM-CSF vaccine. Cancer Immunol Immunother (2006) 0.85
Breast cancer screening compliance among young women in a free access healthcare system. J Surg Oncol (2008) 0.85
Thyroid cancer yield in patients with Graves' disease selected for surgery on the basis of cold scintiscan defects. Thyroid (2002) 0.85
Evaluation of BRCA1 mutations in an unselected patient population with triple-negative breast cancer. Breast Cancer Res Treat (2012) 0.85
Vaccination with a HER2/neu peptide induces intra- and inter-antigenic epitope spreading in patients with early stage breast cancer. Surgery (2006) 0.84
The Clinical Breast Care Project: an important resource in investigating environmental and genetic contributions to breast cancer in African American women. Cell Tissue Bank (2007) 0.84
Chromosomal alterations associated with the transition from in situ to invasive breast cancer. Ann Surg Oncol (2008) 0.84
Pain ratings by patients and their providers of radionucleotide injection for breast cancer lymphatic mapping. Pain Med (2012) 0.83
Differential gene expression in primary breast tumors associated with lymph node metastasis. Int J Breast Cancer (2011) 0.83
Racial variation in breast cancer treatment among Department of Defense beneficiaries. Cancer (2011) 0.83
Evaluation of the HER2/neu-derived peptide GP2 for use in a peptide-based breast cancer vaccine trial. Cancer (2006) 0.83
FH535 inhibited migration and growth of breast cancer cells. PLoS One (2012) 0.83